Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IBTX: another insider filing, $.5M, just filed
IBTX: Lots of insider buying above and around this price. I have reloaded. Not a daytrade
http://www.secform4.com/insider-trading/1564618.htm
DW: bite time took some 40.60 on sell off from headline miss. Miss was not what it appears and was a beat on revs.
...In connection with the sale of the aluminum extrusion-related assets in April 2014, the Company recorded an after-tax charge of $1.2 million. Excluding this charge, net income in the second quarter of 2014 would have been $19.8 million, or $0.82 per diluted share.
IRIX was a miss on eps, however I heard nothing on the cc to dampen my long term perspective on this company. R&D had higher costs than previously expected but has significant and near term returns. I have no idea how this one will trade but I will add more if it falls. The products from this company are being widely accepted as evidenced by rev growth and with an aging world and US population the movement to this type of treatment is more cost effective and provides better results than traditional treatments. It is nice to be ahead of the tipping point IMO.
Gapper IRIX earnings play and I hold a fair amount as a long term hold
that was me covering>re:GALT! A $120,000 BUY, RIGHT BEFORE THE BELL! BOOOM!
to the hall of shame...TWTR pick ;)
Good post timing. Filing out this morning. Will mention that I think this IPO will be well received and should climb.
http://www.sec.gov/Archives/edgar/data/1606363/000110465914054184/a14-10949_5fwp.htm
http://www.sec.gov/Archives/edgar/data/1606363/000104746914006457/0001047469-14-006457-index.htm
Houston's Green Bancorp should be worth considering whenever they do their IPO. It is a competitor to some degree with IBTX which I have more than doubled my money on. Texas is a hot market. I have been looking it over and so far like what I see. This post is to make folks aware of it. We all have time to do our DD before they actually start trading. Just giving a heads up.
http://www.houstonchronicle.com/business/article/Houston-s-Green-Bank-to-go-public-5575699.php
IBTX, soaked up a few 48.80. Texas bank that I have made good money on. Hope to continue that. Insiders buying at this price and above. Earnings soon
That is not him? Never know what to believe any more
Z:just tradin, reshort 155.50
BJRI +14% out 1/3 35.00
ABAX small short 46.80 daytrade only
BJRI should run..rippin BJ's Restaurants price target raised to $43 from $38 at Stifel
RRMS: announced today that the Board of Directors of its general partner has declared a cash distribution for the second quarter of 2014 of $0.535 per unit, or $2.14 per unit on an annualized basis. This distribution represents an increase of approximately 8% over the prior quarter's distribution of $0.495 per unit, and an approximately 22% increase over the second quarter of 2013 quarterly distribution of $0.44 per unit.
This continues to be a wonderful long term hold. Makes the yield on my $21 shares over 10% now with share price appreciation. Current share price $56.
$Z $TRLA rumors just ridiculous Top 10 real estate websites COMBINED do not account for more than 50% of total real estate traffic
Citron Research @CitronResearch
Gapper BJRI and I dont like restaurant stocks....just sayin
Has already taken two beatings in last few months. One would think the downside is limited. No position currently but will watch for op to get long trade only
Z short 149.50 for trade
NNBR: 29.20 on 2 day climb from nice acqusition.
LCI:After Lannett fell 17% following the disclosure that it had received subpoenas from Connecticut regarding the pricing of digoxin, Roth Capital does not expect the state to take any further action against the company. The firm does not believe that there has been any collusion on digoxin prices. It keeps a $45 price target and Buy rating on the shares.
Not sure I will touch this one today but will be watching for sure
IPXL:I guess subpoena from CT Attorney General regarding price fixing is no big deal
LNN: may lose the $80 line today
AAN covered more 29.25>short 32.25 on warning
AAN covered some 30.21>short 32.25 on warning
30.67>AAN: short 32.25 on warning and downward revision
**kicks self one more time for good measure
**jj kicks self $4.27>covered 5.1 FHCO, short a few 5.40
AAN: short 32.25 on warning and downward revision
(edit, never mind, covered 5.10)FHO, short a few 5.40 on removal of divy, just looking for scalp
In order to position the Company to pursue a growth strategy, the Board of Directors has elected to suspend the payment of quarterly dividends at the present time and devote cash flows towards these strategic initiatives that have the potential to accelerate the Company's long-term growth in revenue and earnings."
Best wishes DC. You will be missed here and hope you are able to return soon.
RRMS: $57.08 and keeps setting new highs. Barclays out with new $62 target yesterday. Goes with Goldman's $61 target. What a sweet ride this has been.
Rose Rock Midstream (NASDAQ:RRMS)‘s stock had its “overweight” rating restated by equities researchers at Barclays in a research report issued on Monday. They currently have a $62.00 price objective on the stock, up from their previous price objective of $47.00. Barclays’ price target would indicate a potential upside of 14.77% from the stock’s previous close.
Rose Rock Midstream (NASDAQ:RRMS) traded up 0.42% on Monday, hitting $54.2445. 72,544 shares of the company’s stock traded hands. Rose Rock Midstream has a 1-year low of $31.49 and a 1-year high of $54.11. The stock’s 50-day moving average is $46.44 and its 200-day moving average is $40.90. The company has a market cap of $1.440 billion and a price-to-earnings ratio of 34.19.
Rose Rock Midstream (NASDAQ:RRMS) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by $0.02. The company had revenue of $290.92 million for the quarter, compared to the consensus estimate of $252.26 million. The company’s revenue for the quarter was up 69.9% on a year-over-year basis. On average, analysts predict that Rose Rock Midstream will post $1.84 earnings per share for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Goldman Sachs initiated coverage on shares of Rose Rock Midstream in a research note on Thursday, June 19th. They set a “buy” rating and a $61.00 price target on the stock. Separately, analysts at Robert W. Baird downgraded shares of Rose Rock Midstream from an “outperform” rating to a “neutral” rating in a research note on Thursday, June 12th. They now have a $49.00 price target on the stock. They noted that the move was a valuation call. Finally, analysts at Deutsche Bank raised their price target on shares of Rose Rock Midstream from $44.00 to $52.00 in a research note on Monday, June 9th. They now have a “buy” rating on the stock. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $49.73.
Rose Rock Midstream, L.P. owns, operates, develops and acquires a diversified portfolio of midstream energy assets.
GPRO: so glad no short shares were available this morning when I checked.
GPRO: I think you may be right. Whether it gaps down or not we shall see but it should take a fall tomorrow. I believe short shares become available to most retail traders tomorrow. 3 business days of closing from day 1 makes those shares available tomorrow.
Lucky day, exit on DMD and GTT .01 from hod on each